5151 - 5175 of 9117 Results
Title
Year
-
OPENTitle: Mechanisms of Alpha-Synuclein-Seeded Aggregation in Neurons Revealed by Fluorescence Lifetime ImagingJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 16Issue #: 11Start Page: 2128End Page: 2140Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.5c00236Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.5c00236?ref=article_openPDFCitation Count: 2
-
OPENTitle: Digital health technology for Parkinson's disease with comprehensive monitoring and artificial intelligence-enabled haptic biofeedback for bulbar dysfunctionJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 3Start Page: 630End Page: 645Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251329354Best OA location URL: https://doi.org/10.1177/1877718x251329354Citation Count: 9
- Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial2019RESTRICTEDTitle: Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 145End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30405-8Citation Count: 122
-
OPENTitle: Inhibition or genetic reduction of ASAH1 /acid ceramidase restore α-synuclein clearance in mutant GBA1 dopamine neurons from Parkinson’s patientsJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 34Issue #: 24Start Page: 2075End Page: 2087Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddaf166Best OA location URL: https://academic.oup.com/hmg/advance-article-pdf/doi/10.1093/hmg/ddaf166/65278149/ddaf166.pdfCitation Count: 1
-
OPENTitle: Arm swing as a potential new prodromal marker of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1527End Page: 1534Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26720Best OA location URL: http://doi.org/10.1002/mds.26720Citation Count: 181
-
RESTRICTEDTitle: Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 HeteromersJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 9Start Page: 1201End Page: 1211Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00036Best OA location URL: http://doi.org/10.1021/acschemneuro.6b00036Citation Count: 58
- Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson’s disease2020RESTRICTEDTitle: Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 9Start Page: 2582End Page: 2588Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-09856-7Citation Count: 10
-
OPENTitle: Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic lossesJournal Name: NeuroImagePublisher: Elsevier BVVol: 149Issue #:Start Page: 295End Page: 304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.02.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5386784Citation Count: 50
-
OPENTitle: Stimulation-induced reversed plus-minus syndrome: Insights into eyelid physiologyJournal Name: Brain StimulationPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 951End Page: 952Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.04.010Best OA location URL: https://doaj.org/article/b711f7d9567240b89145b894bc21f1beCitation Count: 3
-
OPENTitle: Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 4Start Page: e14630End Page: e14630Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.14630Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14630Citation Count: 13
-
OPENTitle: Can Isolated Enlarged Virchow‐Robin Spaces Influence the Clinical Manifestations of Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 1Start Page: 67End Page: 69Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12009Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12009Citation Count: 17
- Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD2018RESTRICTEDTitle: Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PDJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 89Issue #: 9Start Page: 989End Page: 994Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2018-318060Citation Count: 81
- Memory impairment in Parkinson’s disease: The retrieval versus associative deficit hypothesis revisited and reconciled.2019RESTRICTEDTitle: Memory impairment in Parkinson’s disease: The retrieval versus associative deficit hypothesis revisited and reconciled.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 33Issue #: 3Start Page: 391End Page: 405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000503Citation Count: 36
-
OPENTitle: Role for NUP62 depletion and PYK2 redistribution in dendritic retraction resulting from chronic stressJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 111Issue #: 45Start Page: 16130End Page: 16135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1418896111Best OA location URL: https://www.pnas.org/content/pnas/111/45/16130.full.pdfCitation Count: 51
-
OPENTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8369681Citation Count: 30
- A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's disease2023RESTRICTEDTitle: A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105325End Page: 105325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105325Citation Count: 0
-
OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6592621Citation Count: 12
-
OPENTitle: Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein DestabilizationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 8Start Page: 5273End Page: 5286Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-018-1449-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-018-1449-2.pdfCitation Count: 19
-
OPENTitle: APOE ‐stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's DiseaseJournal Name: Advanced SciencePublisher: WileyVol: 13Issue #: 21Start Page: e13872End Page: e13872Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202513872Best OA location URL: https://doi.org/10.1002/advs.202513872Citation Count: 0
- Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”2025RESTRICTEDTitle: Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”Journal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 10Start Page: 2287End Page: 2288Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.70053Citation Count: 0
-
OPENTitle: Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/564812Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/564812.pdfCitation Count: 4
-
OPENTitle: Variants in the Niemann–Pick type C gene NPC1 are not associated with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 93Issue #:Start Page: 143.e1End Page: 143.e4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.03.021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7302975Citation Count: 21
- Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains2018RESTRICTEDTitle: Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brainsJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 309Issue #:Start Page: 91End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.016Citation Count: 52
-
OPENTitle: Is Levodopa Response a Valid Indicator of Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 948End Page: 954Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28406Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8046721Citation Count: 41
- Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case2017OPENTitle: Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s caseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 75End Page: 75Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0482-0Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0482-0Citation Count: 128